The recent trend across the cannabis sector has focused mainly on two things:
1. Marijuana Legalization
2. Canada’s growing market
But we’re all missing something right now that could result in a huge missed opportunity.
That “little thing” is the fact that there’s an entire country to the south of Canada that includes a handful of states that dwarf the sales of the entire country of Canada.
The opportunity for marijuana stocks in the US is too big to ignore in our opinion. While the bigger funds and day traders target “the next big Canadian pot stock,” the smart money bets may be on those companies “south of the border” and we don’t mean Mexico. We’re talking the land of the red, white and blue, the United States.
The global legal marijuana market size was valued at USD 9.3 billion in 2016 and is expected to exhibit a CAGR of 34.6% during the forecast period. The market is expected to witness significant growth owing to legalization in several countries and high demand for both medical and recreational purposes.
Over the past few years, the number of companies operating in this market has grown by leaps and bounds. Producers are focused on expanding their customer base by offering a wide portfolio of products and through geographical expansion.
Products currently being offered include varieties of strains and extracts such as oils, tinctures, resins, and consumables based on the concentration of cannabinoids like THC and CBD.
CLS Holdings USA, Inc. (CLSH) Is Plotting A Course For Rapid Expansion Across The US
CLS Holdings (CLSH) is a diversified cannabis company operating as Cannabis Life Sciences and an integrated cannabis producer and retailer in Nevada through its Oasis Cannabis subsidiaries. The Company has taken aim at expanding its footprint beyond Nevada and is strategically positioning itself in some of the fastest growing US markets right now.
This could pose a very immediate and direct correlation to the anticipated industry growth and what may lie ahead for CLS Holdings (CLSH). The Company’s business model includes licensing operations, processing operations, processing facilities, the sale of products, and brand creation.
A Focus On Nevada’s Growing Pot Industry
According to the Nevada Department of Taxation, marijuana flower/bud accounted for roughly 50% of all combined medical and adult-use marijuana purchases by consumers in Nevada, followed by concentrates at about 25% and infused edibles at 13%.
Earlier this year, CLS Holdings (CLSH) closed on its acquisition of Oasis Cannabis. Oasis announced that packaged marijuana flower/bud and pre-rolled joints represented 67% of the total sales, followed by concentrates at 20% and infused edibles at 9%.
Oasis Cannabis served over 127,000 customers in its 1st year of adult-use sales. About 13% of those orders and 22% of total sales were to medical patients. The average order from a medical customer was $73 whereas a typical recreational customer spent $41 per order.
Furthermore, home deliveries made up 5 percent of the total orders and 11% of total revenue, reflecting a higher average order of $98 versus $42 from in-store customers. The average delivery order from a medical customer was $114 and the average delivery to a recreational customer totaled about $87.
Oasis’s City Trees wholesale product line recently more than doubled its number of product SKUs offered to retail dispensary customers, and now covers a variety of concentrates, vape pens, and capsules, and tinctures including high CBD versions. The City Trees product line is now being sold in over 20 dispensaries in the Las Vegas and Reno markets.
CLS Holdings (CLSH) And A $27.9 Million Acquisition Opens BIG DOORS In Nevada
This growth could be at the very early stages. When it comes to Nevada, Las Vegas commands a huge tourist population. Oasis Cannabis has opened a key dispensary in downtown Las Vegas, easy access from Strip that provides direct access to Clark County’s 45 million annual tourists. The storefront is large enough to accommodate approximately 800 customers…per day.
For CLS Holdings (CLSH), this acquisition of Oasis, valued at nearly $28 million, is much more than just obtaining access to a dispensary. Within the 22,000 square foot Oasis warehouse, 4,000 square feet is currently allocated to production efforts and 18,000 square feet is allocated toward cultivation efforts, which could allow CLS to grow more than 4,500 pounds of flower per year according to the company.
At CLS, its proprietary extraction and conversion method allows the company to manufacture a broad variety of products ranging from solid and oil concentrates to infused products and edible marijuana products. This technology is expected to reduce growing costs and provide double the amount of Delta-9 THC compared to our competitors.
It can also produce cleaner and safer products as a result of advanced testing. In fact, CLS Holdings (CLSH) has received a Notice of Allowance from the U.S. Patent Office for its proprietary extraction and conversion methodology.
The company has built a framework to become vertically integrated into its business model. From seed to sale and everything in between, with an initial focus on one of the most prolific tourist markets in the world that just so happens to have full legalization.
Recreational marijuana sales became legal in Nevada on July 1, 2017. In the year that’s passed, cash has flowed, businesses have grown and no major controversies have surfaced. Nevada dispensaries sold nearly $425 million (1) worth of recreational marijuana and pulled in nearly $70 million in tax revenue in the state’s first full year of sales.
Let’s just look at the landscape. In 2014, Colorado was the hottest ticket in terms of legal recreational marijuana. The state sold a cool $700 million (2) of marijuana in 2014 with no competition besides what little medical cannabis sales there were in other states. Comparatively speaking, today there is much more competition yet Nevada could be presenting immense opportunity due to its built-in tourism business. CLS Holdings (CLSH) has a front row seat.
Expanding Beyond Its $425 million Market & Into One That Could Hit $1.8 BILLION!
CLS Holdings (CLSH) has gone far beyond focusing on a single locale and it’s putting its money where its mouth is. Not only has the company raised tens of millions in operating capital over the last few months, but it has also begun to deploy that to the tune of multi-million dollar deals. This translates into CLS Holdings (CLSH) expanding its operating footprint across the US in some of the up and coming legal cannabis markets.
In the 4th quarter of 2018, the company loaned $5 million to In Good Health, a licensed medical dispensary in Brockton, Massachusetts with a significant market share.
Massachusetts has a population of 6.9 million people as compared to 5.6 million people in Colorado. Massachusetts is also centrally located to the dense population of New England with a less than 100-mile drive from Rhode Island, Connecticut, New York, New Hampshire, and Vermont.
In 2017, Colorado generated $1.5 billion in legalized marijuana sales and had over 500 licensed dispensaries and over 700 licensed cultivation facilities. Massachusetts currently has issued only 39 licensees. After the first five days of adult-use cannabis sales in Massachusetts—between only two licensed dispensaries statewide—customers purchased more than $2.2 million worth of cannabis products, according to data released by the state’s Cannabis Control Commission (3). Numbers like those follow early estimates that the Massachusetts adult-use cannabis market could hit $1.8 billion(4)!
In Good Health is located 25 miles south of downtown Boston. The Brockton dispensary was the second licensed dispensary in the state and has been operational since September 2015, which has been medical only up until this time. In Good Health is currently servicing 17,000 registered patients and delivering to 1,700 homes with key product offerings of flower, concentrates, vapes, edibles, pre-rolls, and tinctures.
CLS Holdings (CLSH) has also agreed to form a joint venture with CannAssist, which CLS will own 80%. CannAssist has entered into a contract with the City of Leicester and has applied for a state cultivation grow license. The planned Leicester 86,000 square foot facility is expected to produce its first harvest in Q1 of 2020. This facility is expected to produce 28000 pounds of flower along with 240,000 grams of extract.
At current pricing of $3,500 per pound of flower and $40 per gram of extract, total capacity is expected to reach $120 million in revenue. CLS Holdings (CLSH) anticipates generating substantial positive cash flow from the joint venture, which could directly translate to market potential for Wall Street!
This agreement, along with the previously announced option agreement to acquire In Good Health, marks a continuation towards CLS’s goal to become a significant entity in the rapidly growing Massachusetts market.
CLS Holdings Focused On Real Growth
CLS Holdings (CLSH) is working to stand above its competition. The cannabis arena is still very young and it isn’t unlikely to see a company not produce revenue…but the market get excited. In the case of CLSH, there could be much more to get excited about here than just the company being in the cannabis arena…that has a lot to do with revenue.
The Company generated revenues of approximately $2.4 million during the third quarter, which is an improvement of 25% over the revenues of Alternative Solutions, LLC, whch was a privately held company during the comparable quarter of the previous year.
Alternative Solutions was acquired by CLS Holdings USA, Inc. in June 2018. The Oasis Dispensary located in Las Vegas, Nevada generated approximately $1.4 million of this amount, up 10% when compared to the revenues it generated for Alternative Solutions, LLC during the comparable period of the previous year. Gross margin at the Oasis Dispensary for the quarter finished at 39.0%, up from 22.3% when compared to the gross margin for Alternative Soutions, LLC for the same quarter of the prior year.
And this growth continues! For the month of April 2019 the company hit record revenue of $1,141,574.50 USD. Results are compared to those of Alternative Solutions, LLC, the entity CLS acquired in June 2018 that operates Oasis and City Trees. Furthermore, CLS Holdings’ Oasis dispensary saw record April 2019 revenue of $652,500 , an increase of 56% from April 2018.
Other Key Highlights:
- The dispensary serviced a record 15,040 customers in the month
- City Trees, the Company’s branded product division, saw a revenue increase from $236,456 in April 2018 to $489,074 in April 2019, a 52% increase.
- Gross margin increased from the 37% gross margin of Alternative Solutions in 2018 to 44% for the Company in 2019
- City Trees increased its customer base from 17 in April 2018 to 32 in April 2019 a 47% increase
“Many of the initiatives management has put in place since the beginning of 2019 are starting to show significant results. The team in Las Vegas is functioning at a high level and although we are less than halfway through May we continue to see improved results in all categories. The combined operating divisions are operating profitably, and we will continue to work hard improving results with a focus on providing exceptional customer service to all our highly valued customers.” said Andrew Glashow, President, and COO of the Company.
And CLSH hasn’t slowed down either, topping results for May. The company showed revenue of $1,058,867 USD. Results are compared to those of Alternative Solutions, LLC, the entity CLS acquired in June 2018 that operates Oasis and City Trees.
- CLS Holdings’ Oasis dispensary saw record May 2019 revenue of $684,500, an increase of 55% from May 2018
- The dispensary serviced a record 16,008 customers in the month, a 70% increase from May 2018
- City Trees, the Company’s branded product division, saw a 189% revenue increase to $374,440 from $129,665 in May 2018
- Gross margin increased from the 39% gross margin of Alternative Solutions in 2018 to 45% for the Company in 2019
- City Trees increased its active customer base from 10 in May 2018 to 46 in May 2019
Oasis Cannabis Dispensary continues to increase foot traffic from 9,400 on May of 2018 to 16,000 in May of 2019, an increase of more than 6,600 customers served or 70%.
What Are Analysts Saying Right Now?
CLS Holdings (CLSH) has also attracted attention from wealth management firms. One of these has been Canaccord Genuity. The firm actually highlights some of the same things we’ve mentioned to support their bullish stance on the company:
CLSH – Well-positioned in Brockton
We toured In Good Health’s production and retail facility and met with both the CEO of In Good Health David Noble and CLSH’s recently named COO Andrew Glashow. As previously mentioned, CLSH has a binding agreement to acquire In Good Health for a total consideration of $47.5M. The acquisition agreement is locked in and CLSH will be able to officially close the transaction after November 1st when In Good Health has been in operation as a not-for-profit entity for more than one year.
…With the City of Brockton having finalized zoning ordinances, we expect CLS will finalize a recreational application in the next few weeks and receive a license to commence sales in early Q3. Importantly, with the company’s footprint the dispensary has parking capacity for more than 225 cars which likely eliminates the capacity challenges experienced by some of the other recently opened recreational stores in Massachusetts. In addition to the existing operations, we viewed the company’s ongoing expansion initiatives (funded in part by a $5M loan from CLSH).
Construction is underway to add approximately 30,000 sq. feet of cultivation to the company’s existing 26,000 sq. ft footprint and double production space from 1,000 sq. ft to 2,000. In conjunction with the expansion, production capacity for oil will increase from 1,500 lbs. of concentrates annually to more than 3,500 lbs. Management believes the cultivation project will be completed next month with the first harvest sixty days thereafter.
We note that in addition to that, In Good Health has an outstanding LOI to acquire an 80% interest in a CannAssist cultivation and production facility project. CannAssist is owned by the In Good Health CEO and is developing a cultivation and production facility in Leicester, MA which will be designed to yield up to 28,000 lbs. of flower annually and capable of processing up to 12,600 of flower and trim per year. We expect the company to receive a license (the application has been submitted with the state and Leicester as a host community has approved the project) and for the acquisition to close this year with contributions to the model coming in 2020. Longer term, it will serve as a wholesale arm for CLSH. In 2020, we expect Leicester to represent approximately 39% of our CLSH Massachusetts revenue estimate with Brockton representing the remaining sales.
The Road Ahead
CLS Holdings (CLSH) has an expanding footprint into high growth regions of the US and is building its model not on one single aspect but upon an entire vertically integrated strategy to allow for full control of its revenue streams.
The company’s management team has 120+ years of collective experience in capital markets; medical and real estate lends itself well to pursuing – and executing on – M&A transactions across the United States.
CLS Holdings (CLSH) is looking to acquire cannabis opportunities across the United States where medical and recreational marijuana businesses are prosperous with large potential growth and expansion. The investments in the Brockton and Leicester facilities will establish a presence on the east coast where CLS Holdings (CLSH) hopes to pursue additional opportunities that will enhance the current offering that it has in Nevada.
Following Canada’s legalization, we’re seeing even more interest build across the North American market. An increasing number of companies operating in the marijuana market is expected to bolster the quantity and variety of products reaching the end users. Recent, multi-billion dollar investments from the likes of Molson-Coors, Constellation Brands, and Altria have opened up Pandora’s box to new opportunities…and with that, new attention from BIG MONEY.
Products like marijuana oil have started gaining traction over the past few years owing to increased effectiveness and safety as compared to smoking it. Also, the growing research in the cannabis industry has led to the introduction of new marijuana strains. These advances in new product development are expected to enhance product adoption among consumers. With the U.S. legal marijuana market expected to grow at a CAGR of 24.9% from 2017 to 2025 from it’s estimated 7.06 billion in 2016, the next opportunity for marijuana stocks could be right in our backyard.
Disclaimer: Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC (owners of MarijuanaStocks.com), Midam Ventures LLC and CLS Holdings USA Inc. (CLSH), Midam has been paid $200,000 from CLS Holdings USA Inc. (CLSH) for a period from April 26, 2019, (NOW EXTENDED TO) to July 26, 2019. We may buy or sell additional shares of (CLSH) in the open market at any time, including before, during or after the Website and Information, to provide public dissemination of favorable Information about CLS Holdings USA Inc. (CLSH). Click here for full disclaimer
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | email@example.com